CCND2 and breast carcinoma: To our knowledge, we are the first to show, using resources from a population-based follow-up study, that promoter methylation of APC, CCND2, HIN1, and TWIST1 may modify the inverse association between prediagnostic RPA and all-cause mortality following a breast cancer diagnosis.